| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director, 10% Owner | Director
4 companies
Foley Todd is a Director, 10% Owner at TRDA with holdings across 4 companies. Recent SEC Form 4 filings include 1 buy and 26 sells.
Estimated insider holdings value: $303.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2, 2021 | RPTX Repare Therapeutics Inc. | Director | Sell | 16,786 | $32.47 | $545,041.33 | -0.2% | +5.9% | -60.5% | |
| May 27, 2021 | RPTX Repare Therapeutics Inc. | Director | Sell | 16,989 | $32.82 | $557,634.95 | -0.1% | +7.2% | -72.5% | |
| May 24, 2021 | RPTX Repare Therapeutics Inc. | Director | Sell | 143,141 | $34.75 | $4,974,688.42 | -1.9% | +0.3% | -73.8% | |
| May 20, 2021 | RPTX Repare Therapeutics Inc. | Director | Sell | 27,136 | $34.25 | $929,519.17 | -0.2% | -2.6% | -75.5% | |
| Mar 15, 2021 | RYTM Rhythm Pharmaceuticals, Inc. | Director | Sell | 1,000,000 | $25.10 | $25,100,000.00 | -52.4% | -21.3% | -63.0% | |
| Mar 12, 2021 | RPTX Repare Therapeutics Inc. | Director | Sell | 376,412 | $28.18 | $10,607,290.16 | -12.5% | +19.5% | -56.9% | |
| Jun 26, 2020 | RYTM Rhythm Pharmaceuticals, Inc. | Director | Sell | 300 | $25.04 | $7,512.00 | - | - | - | |
| Jun 25, 2020 | RYTM Rhythm Pharmaceuticals, Inc. | Director | Sell | 115,335 | $25.35 | $2,923,845.19 | -2.9% | - | - | |
| Jun 23, 2020 | RPTX Repare Therapeutics Inc. | Director | Buy | 250,000 | $20.00 | $5,000,000.00 | +9.1% | - | - | |
| Jun 5, 2020 | RYTM Rhythm Pharmaceuticals, Inc. | Director | Sell | 1,896 | $20.00 | $37,920.00 | - | - | - |